SFM
Sphera Funds Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-211,326
| Closed | -$16.3M | – | 53 |
|
|
2022
Q1 | $16.3M | Sell |
211,326
-5,651
| -3% | -$436K | 2.3% | 11 |
|
|
2021
Q4 | $19.2M | Buy |
216,977
+67,960
| +46% | +$6M | 2.11% | 10 |
|
|
2021
Q3 | $11.5M | Buy |
+149,017
| New | +$11.5M | 0.97% | 23 |
|
|
2020
Q1 | – | Sell |
-251,382
| Closed | -$21.3M | – | 79 |
|
|
2019
Q4 | $21.3M | Buy |
+251,382
| New | +$21.3M | 1.75% | 7 |
|
|
2018
Q4 | – | Sell |
-88,000
| Closed | -$8.53M | – | 105 |
|
|
2018
Q3 | $8.53M | Buy |
88,000
+81,750
| +1,308% | +$7.93M | 0.98% | 22 |
|
|
2018
Q2 | $589K | Buy |
+6,250
| New | +$589K | 0.08% | 95 |
|
|
2018
Q1 | – | Sell |
-35,000
| Closed | -$3.12M | – | 110 |
|
|
2017
Q4 | $3.12M | Sell |
35,000
-50,000
| -59% | -$4.46M | 0.37% | 66 |
|
|
2017
Q3 | $7.91M | Buy |
85,000
+10,000
| +13% | +$931K | 1.13% | 16 |
|
|
2017
Q2 | $6.81M | Buy |
+75,000
| New | +$6.81M | 1.16% | 17 |
|
|
2017
Q1 | – | Sell |
-45,000
| Closed | -$3.73M | – | 109 |
|
|
2016
Q4 | $3.73M | Buy |
+45,000
| New | +$3.73M | 0.94% | 27 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 108 |
|
|
2016
Q1 | – | Sell |
-3,700
| Closed | -$388K | – | 88 |
|
|
2015
Q4 | $388K | Sell |
3,700
-121,300
| -97% | -$12.7M | 0.06% | 108 |
|
|
2015
Q3 | $13.2M | Buy |
125,000
+65,000
| +108% | +$6.85M | 1.68% | 9 |
|
|
2015
Q2 | $8.21M | Sell |
60,000
-20,000
| -25% | -$2.74M | 0.8% | 17 |
|
|
2015
Q1 | $9.97M | Hold |
80,000
| – | – | 1.04% | 13 |
|
|
2014
Q4 | $7.23M | Sell |
80,000
-41,970
| -34% | -$3.79M | 1.23% | 17 |
|
|
2014
Q3 | $8.8M | Buy |
121,970
+1,970
| +2% | +$142K | 1.09% | 18 |
|
|
2014
Q2 | $7.47M | Buy |
+120,000
| New | +$7.47M | 1.84% | 10 |
|